Tempus AI (NASDAQ:TEM) delivered a very mixed Q4 2024 earnings report that saw its shares sell off about 15% after hours. The main takeaway here is that Tempus' core business is expected to grow ...

Google Agreement: Extended for another five years. Tempus AI Inc (NASDAQ:TEM) reported a 35.8% year-over-year revenue growth in Q4 2024, with gross profit growth accelerating to 49.7%. The company ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Please go ahead. Thank you, Jason. Good afternoon and welcome to Tempus' Fourth Quarter 2024 Conference Call. This afternoon Tempus released results for the quarter and year ended December 31 ...

Tempus is expected to releases its 2024 fiscal-year fourth-quarter earnings report after the market closes. Analysts estimate a loss per share of 20 cents and revenue of $203.12 million. Get 5 ...

These speculations have surged in the past month after her investment in AI healthcare firm Tempus AI (NASDAQ:TEM) surged over 300% since 14th January. According to the latest periodic transaction ...

Just a few weeks ago, Tempus AI (NASDAQ: TEM) rocketed from about 44% higher. All on news it just acquired Ambry Genetics and on news, Nancy Pelosi took a stake in the TEM stock by buying 50 of ...

MP SPEAKS | One of the first things I did when I became an MP in 2013 was to read Lim Kit Siang’s “Time Bombs in Malaysia: Problems of Nation-building in Malaysia”. The book was a ...

The financing is intended to support Tempus’ previously announced acquisition of Ambry Genetics ("Ambry"), which closed on February 3, 2025. Combined with $260 million of capital provided in ...